BACKGROUND: Established in the Americas since late 2013, chikungunya is an emerging infection among travellers. OBJECTIVE: To examine demographic and travel correlates of chikungunya among Canadian travellers to establish a detailed epidemiological framework of this infection for Canadian practitioners encountering prospective and returned travellers. METHODS: Data regarding ill returned Canadian travellers presenting to a CanTravNet site between 2006 and 2015 were analyzed. RESULTS: During the study period, 22,387 ill travellers and immigrants presented to a CanTravNet site and, of these, 118 (0.5%) received a diagnosis of chikungunya. Those travelling for tourism were the most well-represented (n=49, 41.5%), followed by those travelling to visit friends and relatives (n=36, 30.5%). The Caribbean was the most likely source region, accounting for 64 (54.2%) diagnoses, followed by South Central Asia (n=18, 15.3%). Haiti was the most well-represented source country, accounting for 22 (18.6%) cases. India, a high-volume destination for Canadians and the next most well-represented source country, accounted for 15 cases (12.7%), as did Jamaica. Median trip duration of those with chikungunya was 14 days, with 51.7% (n=61) having a trip duration of ≤2 weeks and 21.2% (n=25) ≤1 week. Musculoskeletal complaints at presentation were noted in 89% (n=105), followed by fever in 54.2% (n=64). CONCLUSIONS: The present analysis provides an epidemiological framework of chikungunya for Canadian practitioners encountering prospective and returned travellers. It reflects the emergence of chikungunya in the Americas, the risk associated with short-duration travel and substantiates efforts to educate travellers about the need for mosquito avoidance.